1887

Journal of General Virology

Volume 78, Issue 10

Altered antigenicity of 'a' determinant variants of hepatitis B virus Free

Abstract

The ‘a’ determinant of hepatitis B virus (HBV) surface antigen (HBsAg) is the most important target for diagnosis and immunoprophylaxis. Several HBV variants with point mutations within the ‘a’ determinant have been identified among fully vaccinated children in Taiwan. We investigated the effect of each of these mutations on the antigenic nature of the S protein by cloning and expression of the mutant S antigens in . Four variants, Ser-126, His-129, Arg-129 and Arg-145, all exhibited various degrees of altered binding of HBsAg to several monoclonal antibodies. Arg-145, a well-characterized immune escape mutant, and Arg-129 had the lowest binding capacities to all monoclonal antibodies as compared with other variants. Similar to Arg-145, the Arg-129 variant could be isolated from both vaccinated children and unvaccinated adults, thus representing a naturally occurring mutant with an altered ‘a’ determinant. Whether these ‘a’ determinant variants with altered antigenicity might gradually become major circulating strains, as a consequence of the immune pressure against the wild-type HBV created by vaccination, remains to be monitored.

  • Published Online:
© Society for General Microbiology 1997
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-10-2639
1997-10-01
2021-10-27
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/10/9349486.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-10-2639&mimeType=html&fmt=ahah

References

  1. Antoni B. A., Rodriguez-Crespo I., Gomez-Gutierrez J., Nieto M., Peterson D., Gavilanes F. 1994; Site-directed mutagenesis of cysteine residues of hepatitis B surface antigen: analysis of two single mutants and the double mutant. European Journal of Biochemistry 222:121–127
     [Google Scholar]
  2. Ashton-Rickardt P. G., Murray K. 1989; Mutants of the hepatitis B virus surface antigen that define some antigenically essential residues in the immunodominant a region. Journal of Medical Virology 29:196–203
     [Google Scholar]
  3. Brown S. E., Howard C. R., Zuckerman A. J., Steward M. W. 1984; Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides. Lancet ii:184–187
     [Google Scholar]
  4. Bruce S. A., Murray K. 1995; Mutations of some critical amino acid residues in the hepatitis B virus surface antigen. Journal of Medical Virology 46:157–161
     [Google Scholar]
  5. Carman W. F., Zanetti A. R., Karayiannis P., Waters J., Manzillo G., Tanzi E., Zuckerman A. J., Thomas H. C. 1990; Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325–329
     [Google Scholar]
  6. Chirara M. M., Chetsanga C. J. 1994; Variant of hepatitis B virus isolated in Zimbabwe. Journal of Medical Virology 42:73–78
     [Google Scholar]
  7. Chisari F. V., Ferrari C. 1995; Hepatitis B virus immuno- pathogenesis. Annual Review of Immunology 13:29–60
     [Google Scholar]
  8. Cregg J. M., Tschopp J. F., Stillman C., Siegel R., Akong M., Craig W. S., Buckholz R. G., Madden K. R., Kellaris P. A., Davis G. R., Smiley B. L., Cruze J., Torregrossa R., Velicelebi G., Thill G. P. 1987; High-level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast, Pichia pastoris. Biotechnology 5:479–485
     [Google Scholar]
  9. Fortuin M., Karthigesu V., Allison L., Howard C., Hoare S., Mendy M., Whittle H. C. 1994; Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine. Journal of Infectious Diseases 169:1374–1376
     [Google Scholar]
  10. Fujii H., Moriyama K., Sakamoto N., Knodo T., Yasuda K., Hiraizumi Y., Yamazaki M., Sakaki Y., Okochi K., Nakajima E. 1992; Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochemical and Biophysical Research Communications 184:1152–1157
     [Google Scholar]
  11. Guerrero E., Gavilanes F., Peterson D. L. 1988; Model for the protein arrangement in HBsAg particles based on physical and chemical studies. In Viral Hepatitis and Liver Disease pp 606–613 Zuckerman A. J. Edited by New York: Alan R. Liss;
     [Google Scholar]
  12. Harrison T. J., Hopes E. A., Oon C. J., Zanetti A. R., Zuckerman A. J. 1991; Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. Journal of Hepatology 13:S105–S107
     [Google Scholar]
  13. Harrison T. J., Oon C. J., Zuckerman A. J. 1994; A novel antibody escape variant (Ala 144) of hepatitis B virus in an identical twin before selection in the mother. In Viral Hepatitis and Liver Disease pp 248–251 Nishioka K., Suzuki H., Mishiro S., Oda T. Edited by Tokyo: Springer;
     [Google Scholar]
  14. Hino K., Okuda M., Hashimoto O., Ishiko H., Okazaki M., Fujii K., Hanada H., Okita K. 1995; Glycine-to-Arginine substitution at codon 145 ofHBsAg in two infants born to hepatitis B e antigen-positive carrier. Digestive Disease and Sciences 40:566–570
     [Google Scholar]
  15. Ho M. S., Lu C. F., Kuo J., Mau Y. C., Chao W. H. 1995; A family cluster of an immune escape variant of hepatitis B virus infecting a mother and her two fully immunized children. Clinical Diagnosis and Laboratory Immunology 2:760–762
     [Google Scholar]
  16. Howard C. R., Stirk H. J., Brown S. E., Steward M. W. 1988; Towards the development of synthetic hepatitis B vaccines. In Viral Hepatitis and Liver Disease pp 1094–1101 Zuckerman A. J. Edited by New York: Alan R. Liss;
     [Google Scholar]
  17. Howard C. R., Karthigesu V. D., Allison L. M. C., Fortuin M., Mendy M., Whittle H. C. 1994; Hepatitis B virus variants with altered a determinants causing infections in immunized children. In Viral Hepatitis and Liver Disease pp 252–255 Nishioka K., Suzuki H., Mishiro S., Oda T. Edited by Tokyo: Springer;
     [Google Scholar]
  18. Hsu L. C., Lin S. R., Hsu H. M., Chao W. H., Hsien J. T., Wang M. C., Lu C. F., Chang Y. H., Ho M. S. 1996; Ethnic differences in immune responses to hepatitis B vaccine. American Journal of Epidemiology 143:718–724
     [Google Scholar]
  19. Karthigesu V. D., Allison L. M., Fortuin M., Mendy M., Whittle H. C., Howard C. R. 1994; A novel hepatitis B virus variant in the sera of immunized children. Journal of General Virology 75:443–448
     [Google Scholar]
  20. Kohno H., Inoue T., Tsuda F., Okamoto H., Akahane Y. 1996; Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. Journal of General Virology 77:1825–1831
     [Google Scholar]
  21. McMahon G., Ehrlich P. H., Moustafa Z. A., McCarthy L. A., Dottavio D., Tolpin M. D., Nadler P. I., Ostberg L. 1992; in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 15:757–766
     [Google Scholar]
  22. Mangold C. M. T., Streeck R. E. 1993; Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. Journal of Virology 67:4588–4597
     [Google Scholar]
  23. Missale G., Redeker A., Person J., Fowler P., Guilhot S., Schlicht H. J., Ferrari C., Chisari F. V. 1993; HLA-A31- and HLA-Aw68- restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. Journal of Experimental Medicine 773:751–762
     [Google Scholar]
  24. Moriyama K., Nakajima E., Hohjoh H., Asayama R., Okochi K. 1991; Immunoselected hepatitis B mutant. Lancet 337:125
     [Google Scholar]
  25. Ni F., Fang D., Gan R., Li Z., Duan S., Xu Z. 1995; A new immune escape mutant of hepatitis B virus with an Asp to Ala substitution in aa144 of the envelope major protein. Research in Virology 146:397–407
     [Google Scholar]
  26. Okamoto H., Yano K., Nozaki Y., Matsui A., Miyazaki H., Yamamoto K., Tsuda F., Machida A., Mishiro S. 1992; Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatric Research 32:264–268
     [Google Scholar]
  27. Oon C. J., Lim G. K., Ye Z., Goh K. T., Tan K. L., Yo S. L., Hopes E., Harrison T. J., Zuckerman A. J. 1995; Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 13:699–702
     [Google Scholar]
  28. Penna A., Fowler P., Bertoletti A., Guilhot S., Moss B., Margolskee R. F., Cavalli A., Valli A., Fiaccadori F., Chisari F. V. 1992; Hepatitis B virus (HBV)-specific cytotoxicity T-cell (CTL) response in humans: characterization of HLA class Il-restricted CTLs that recognize endogenously synthesized HBV envelope antigens. Journal of Virology 66:1193–1198
     [Google Scholar]
  29. Rothstein R. J. 1983; One-step gene disruption in yeast. Methods in Enzymology 101:202–210
     [Google Scholar]
  30. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual, 2nd edn.. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
     [Google Scholar]
  31. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. 1985; Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150:76–85
     [Google Scholar]
  32. Wallace L. A., Echevarria J. E., Echevarria J. M., Carman W. F. 1994; Molecular characterization of envelope antigen variants of hepatitis B virus from Spain. Journal of Infectious Diseases 10:1300–1303
     [Google Scholar]
  33. Wands J. R., Wong M. A., Shorey J., Brown R. D., Marciniak R. A., Isselbacher K. J. 1984; Hepatitis B viral antigenic structure: signature analysis by monoclonal radioimmunoassays. Proceedings of The National Academy of Sciences USA: 812237–2241
     [Google Scholar]
  34. Waters J. A., Kennedy M., Voet P., Hauser P., Petre J., Carman W., Thomas H. C. 1992; Loss of the common ‘A’ determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. Journal of Clinical Investment 90:2543–2547
     [Google Scholar]
  35. Whittle H. C., Inskip H., Hall A. J., Mendy M., Downes R., Hoare S. 1991; Vaccination against hepatitis B and protection against chronic viral carriage in the Gambia. Lancet 337:747–750
     [Google Scholar]
  36. Yamamoto K., Horikita M., Tsuda F., Itoh K., Akahane Y., Yotsumoto S., Okamoto H., Miyakawa Y., Mayumi M. 1994; Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. Journal of Virology 68:2671–2676
     [Google Scholar]
  37. Zhang Y. Y., Nordenfelt E., Hansson B. G. 1996; Increasing heterogeneity of the ‘a’ determinant of HBsAg found in the presumed late phase of chronic hepatitis B virus infection. Scandinavian Journal of Infectious Diseases 28:9–15
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-10-2639
Loading
Altered antigenicity of 'a' determinant variants of hepatitis B virus
J. Gen. Virol. 78, 2639 (1997); https://doi.org/10.1099/0022-1317-78-10-2639
/content/journal/jgv/10.1099/0022-1317-78-10-2639
/content/journal/jgv/10.1099/0022-1317-78-10-2639
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error